HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

O A Oredipe Selected Research

Swainsonine

11/2003Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice.
11/2003Mice primed with swainsonine are protected against doxorubicin-induced lethality.
1/2003Swainsonine stimulates bone marrow cell proliferation and differentiation in different strains of inbred mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


O A Oredipe Research Topics

Disease

5Neoplasms (Cancer)
11/2003 - 01/2003
2Cardiomyopathies (Cardiomyopathy)
11/2003 - 11/2003
2Neoplasm Metastasis (Metastasis)
11/2003 - 11/2003
1Prostatic Neoplasms (Prostate Cancer)
11/2003
1Pancytopenia
11/2003

Drug/Important Bio-Agent (IBA)

3SwainsonineIBA
11/2003 - 01/2003
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2003 - 11/2003
1matrigelIBA
11/2003
1CytokinesIBA
11/2003
1Interleukin-10 (Interleukin 10)IBA
11/2003
1Cadherins (E-Cadherin)IBA
11/2003
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2003
1E-SelectinIBA
11/2003
1Interleukin-5 (Interleukin 5)IBA
11/2003
1Carbon MonoxideIBA
11/2003
1Cell Adhesion MoleculesIBA
11/2003
1Interleukin-12 (IL 12)IBA
11/2003
1Proteins (Proteins, Gene)IBA
11/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2003

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2003